REFRACTORY LEUKEMIA
Clinical trials for REFRACTORY LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug combo takes aim at relapsed leukemia
Disease control OngoingThis early-phase trial tests a new drug called tegavivint, given together with the chemotherapy decitabine, for people whose leukemia has returned or not responded to standard treatments. The main goals are to find the safest dose and to watch for side effects. Only 9 adults with…
Matched conditions: REFRACTORY LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Italian study tracks how venetoclax works for CLL patients in everyday practice
Knowledge-focused OngoingThis observational study follows 321 Italian patients with relapsed or refractory chronic lymphocytic leukemia (CLL) who are treated with venetoclax-based regimens outside of clinical trials. The goal is to describe their clinical features and outcomes, such as how long they live…
Matched conditions: REFRACTORY LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC